MedTrace Logo

Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice

NCT01368341 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2014-12-12

No results posted yet for this study

Summary

Tick borne diseases are increasing in Norway. Lyme borreliosis is the most common infection. Erythema migrans is mainly diagnosed and treated in general practice. There is disagreement about what antibiotic treatment that should be given. An RCT with the three most common antibiotics used, will support data for revision of national guidelines.

Conditions

  • Erythema Migrans
  • Erythema Chronicum Migrans
  • Borreliosis
  • Lyme Disease
  • Early Lyme Disease

Interventions

DRUG

Doxycycline

1 tablet, 100 mg, b.i.d. 14 days

DRUG

Phenoxymethylpenicillin

Tablet 650 mg, 2 tablets, t.i.d., 14 days

DRUG

Amoxicillin

Capsula, 500 mg, t.i.d., 14 days

Sponsors & Collaborators

  • Norwegian Institute of Public Health

    collaborator OTHER_GOV

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Norwegian University of Life Sciences

    collaborator OTHER

  • Morten Lindbaek

    lead OTHER

Principal Investigators

  • Morten Lindbak, Professor · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-12-31
Completion
2014-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01368341 on ClinicalTrials.gov